Lapatinib and Circulating Tumor Cells in Breast Cancer
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of lapatinib in eradicating chemo- resistant tumour
cells circulating in the blood of patients with breast cancer.